Polysome profiling

This technology is based on the separation of active ribosomes using biotin-modified puromycin (3P complex) and does not require antibodies and labels.

Ribosome Profiling (Ribo-seq) is a translational genomics research technology first published by the Weissman laboratory in 2009 (1).